2024 Here we go again., page-201

I don’t think it’s Surgcenter’s business to do clinical trials by the way. However, given Gregory George’s role as Surgcenter’s founding partner, and the fact that Surgcenter appears still to have ongoing book of business even after its last major transaction, I would not be surprised that he actually saw a business angle in MSB’s product pipeline when he bought into the company, even though his stake is held personally. How that plays out is hard to know, as their lever seems to be on the service, not product, side of equation, but there is no doubt that he should still have at least some influence over the remaining business.